Talus Bio, an LSW Institute WIN Venture, Pioneers Breakthroughs in ‘Undruggable’ Transcription Factors

Talus Bio’s collaborative and innovative approach to unlocking the therapeutic potential of targeting transcription factors for cancer and other diseases is putting them at the forefront of the biotech industry. Tackling the challenge of “undruggable” targets, Talus Bio is working to solve some of the most historically difficult science and medicine in the industry and provide patients with life-saving solutions.